I just found this paper about the clinical trial of SPI-1005 where they evaluated its efficacy for preventing NIHL:
Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
Interestingly, the 600 mg group...